Retatrutide

Metabolic Research Peptide

Retatrutide (LY3437943) is an investigational synthetic peptide studied for its activity at GIP, GLP-1, and glucagon receptors. It is currently the subject of clinical research and is intended here strictly for laboratory research purposes.

Available in 10 mg, 20 mg, 30 mg, and 50 mg.

For laboratory research only. Not for human or veterinary use.

★Earn 800 Rewards Points

How Rewards Work

Price range: $70.00 through $190.00

Strength

Clear

Description

Description
Retatrutide (LY3437943) is an investigational triple receptor agonist targeting GIP, GLP-1, and glucagon receptors, currently in Phase 3 clinical research.

Research Areas

GIP / GLP-1 / Glucagon receptor signaling
Metabolic pathway research
Peptide receptor interactions

Product Details

Product Name: Retatrutide
Development Name: LY3437943
CAS Number: 2381089-83-2
Type: Investigational synthetic peptide
Receptor Activity: GIP/GLP-1/Glucagon agonist
Strengths: 10mg, 20mg, 30mg, 50mg
Use: Laboratory research only

Important Information
Investigational compound, not FDA-approved. Not intended to diagnose, treat, cure, prevent, or manage any medical condition. For laboratory research use only — not for human or veterinary use.

Additional information

Weight	0.2 lbs
Dimensions	2 × 2 × 2 in
Strength	10mg, 20mg, 30mg, 50mg

Reviews

There are no reviews yet.

Be the first to review “Retatrutide”

All Evere Wellness products are intended solely for laboratory and scientific research. Not for human or veterinary consumption, compounding, diagnosis, treatment, cure, or prevention of disease.

Evere Wellness does not provide medical advice, dosing instructions, or treatment recommendations. These statements have not been evaluated by the Food and Drug Administration. These products are not drugs and are not intended to diagnose, treat, cure, or prevent any disease.

Subscribe to our

Subscribe to our newsletter to get daily insights, news, updates.